Stephanie L Alberico1, Martin D Cassell2, Nandakumar S Narayanan1. 1. Department of Neurology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, United States. 2. Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, United States.
Abstract
INTRODUCTION: The involvement of dopaminergic neurons in the ventral tegmental area (VTA) in Parkinson's disease (PD) has not been universally recognized by neuroscientists and neurologists. Here, we conduct a review of previous research documenting dopaminergic neuronal loss in both the substantia nigra pars compacta (SNpc) and VTA and add three new post-mortem PD cases to the literature. METHODS: PD and control brains were sectioned, stained for tyrosine hydroxylase, and cells in the SNpc and VTA were counted. RESULTS: Based on the review, we report two main results: 1) the VTA does degenerate in PD, and 2) the VTA degenerates less than the SNpc. CONCLUSION: Inconsistent clinical information about these cases limits our ability to interpret how the VTA contributes to PD symptoms. However, our data in combination with prior PD neuropathological cases in the literature unequivocally establish that the VTA is involved in PD, and could be relevant for future investigation of non-motor symptoms in PD.
INTRODUCTION: The involvement of dopaminergic neurons in the ventral tegmental area (VTA) in Parkinson's disease (PD) has not been universally recognized by neuroscientists and neurologists. Here, we conduct a review of previous research documenting dopaminergic neuronal loss in both the substantia nigra pars compacta (SNpc) and VTA and add three new post-mortem PD cases to the literature. METHODS:PD and control brains were sectioned, stained for tyrosine hydroxylase, and cells in the SNpc and VTA were counted. RESULTS: Based on the review, we report two main results: 1) the VTA does degenerate in PD, and 2) the VTA degenerates less than the SNpc. CONCLUSION: Inconsistent clinical information about these cases limits our ability to interpret how the VTA contributes to PD symptoms. However, our data in combination with prior PD neuropathological cases in the literature unequivocally establish that the VTA is involved in PD, and could be relevant for future investigation of non-motor symptoms in PD.
Entities:
Keywords:
Parkinson’s disease; Ventral tegmental area
Authors: D Frosini; E Unti; F Guidoccio; C Del Gamba; G Puccini; D Volterrani; U Bonuccelli; R Ceravolo Journal: J Neural Transm (Vienna) Date: 2015-01-23 Impact factor: 3.575
Authors: Carolina Gil-Tommee; Guadalupe Vidal-Martinez; C Annette Reyes; Javier Vargas-Medrano; Gloria V Herrera; Silver M Martin; Stephanie A Chaparro; Ruth G Perez Journal: Exp Neurol Date: 2018-10-25 Impact factor: 5.330
Authors: Saranya Sundaram; Rachel L Hughes; Eric Peterson; Eva M Müller-Oehring; Helen M Brontë-Stewart; Kathleen L Poston; Afik Faerman; Chloe Bhowmick; Tilman Schulte Journal: Neurosci Biobehav Rev Date: 2019-05-24 Impact factor: 8.989
Authors: Young-Cho Kim; Sang-Woo Han; Stephanie L Alberico; Rafael N Ruggiero; Benjamin De Corte; Kuan-Hua Chen; Nandakumar S Narayanan Journal: Curr Biol Date: 2016-12-15 Impact factor: 10.834
Authors: Romina Pes; Sean C Godar; Andrew T Fox; Lauren M Burgeno; Hunter J Strathman; David P Jarmolowicz; Paola Devoto; Beth Levant; Paul E Phillips; Stephen C Fowler; Marco Bortolato Journal: Neuropharmacology Date: 2016-11-23 Impact factor: 5.250